STERIS plc Stock News

These businesses operate on a large scale but with a narrower focus than Amazon.

Investors are optimistic about STERIS (STE) owing to its robust segmental results and the ongoing Cantel Medical integration.

Steris (STE) reported earnings 30 days ago. What's next for the stock?

STERIS plc. (NYSE:STE ) Q4 2022 Earnings Conference Call May 12, 2022 10:00 AM ET Company Participants Daniel Carestio – President and Chief Executive Officer Michael Tokich – Senior Vice Presiden

Robust performances across all four reporting segments drive STERIS' (STE) fiscal fourth-quarter revenues.

It isn't going to be facing disruption anytime soon.

The Zacks Medical - Instruments industry is growing on R&D investments. ALC, STE and ABMD are set to gain the most.

Investors are optimistic about STERIS' (STE) robust segmental growth and noteworthy acquisitions in the healthcare and pharmaceutical spaces.

Investors are optimistic about STERIS (STE) on impressive growth across its operating segments.

Investors are optimistic about STERIS' (STE) robust segmental performance and upbeat 2022 guidance.

Steris (STE) reported earnings 30 days ago. What's next for the stock?

STERIS' (STE) significant revenues from acquisitions of Key Surgical and Cantel Medical appear promising.

STERIS plc (Ireland) found using ticker (STE) now have 4 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 295 and 256 with a mean TP of 271. With the stocks previous close at 244.06 this indicates there is a potential upside of 11.0%. The 50 day MA is 232.78 and the 200 day moving average is 219.68. The company has a market cap of $24,549m. Visit the company website at: https://www.steris.com [stock_market_widget type="chart" template="basic" color="green" assets=STE" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $27,259m based on the market concensus. STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Is it the Wrigley''s gum of healthcare?

Is it the Wrigley's gum of healthcare?